Form 4: Hanover Insurance Group CEO Exercises Options, Sells Shares to Cover Costs
SEC Form 4 Filing
John C. Roche, President and CEO of Hanover Insurance Group, exercised stock options and sold shares to cover the exercise price and associated taxes.
Summary
- On February 27, 2025, John C. Roche, the President and CEO of Hanover Insurance Group, exercised in-the-money stock options.
- A total of 22,943 shares were acquired through the exercise of options at a price of $66.14.
- To cover the exercise price and associated taxes, 15,604 shares were withheld by the company at $166 per share.
- Additionally, on February 28, 2025, 8,826 shares were forfeited to pay withholding taxes upon the vesting of restricted stock units at $170.53 per share.
- Following these transactions, Roche directly owns 124,277.851 shares of common stock.
- The filing also notes that Roche's spouse holds 14,454 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment. It reflects routine compensation-related activities.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options and restricted stock as part of their compensation. These transactions are closely watched by investors for signals about management's confidence in the company's future prospects.
Comparison to Industry Standards
- Executive compensation packages in the insurance industry often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of these options are typically structured to incentivize long-term performance.
- Similar transactions are regularly reported by executives at comparable companies such as Chubb, Travelers, and Progressive.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they involve the issuance and sale of shares by an executive.
- The company withholds shares to cover taxes, which affects the company's share count.
Key Dates
| Date | Description |
|---|---|
| 02/27/2015 | Date of the Option Agreement |
| 02/27/2016 | First vesting date (1/3) of the option |
| 02/27/2017 | Second vesting date (1/3) of the option |
| 02/27/2018 | Third vesting date (1/3) of the option |
| 02/27/2025 | Date of option exercise and share withholding |
| 02/28/2025 | Date of share forfeiture for tax withholding on restricted stock units |
| 03/03/2025 | Date of signature on the Confirming Statement |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.